The Swedish
Association for the Protection of Intellectual Property (SFIR) had its yearly big
event --“The case-law day”-- on the 17th of January, in Stockholm,
Sweden. This gathering is a forum where
the most important case law from the Swedish courts (as well as from the CJEU,
EPO and EUIPO) from the previous year are presented and discussed. The day is
divided in several sessions, each one concerning
a distinct intellectual property right (check the website for the presentations, unfortunately in Swedish www.sfir.se).
photo from previous SFIR conference |
In the
patent session (presented by lawyer
Peter Sande), two cases were in focus--, the 2018-01-31, PMT 2097-15 och PMT
6191-17 Actavis ./. Eli Lilly case and the 2018-11-16, PMT 1387-16 Alfa Laval
./. SWEP case.
The Actavis ./. Eli Lilly case
The Actavis
./. Eli Lilly case concerned the principle of equivalence. The Swedish Patent
and Market Court applied the principles set out in an earlier case, the Easypark case (17 November
2016, mål PMT 744-16), providing that for patent infringement to have been committed
under the principle of equivalence, four
criteria need to be met, namely: i) the inventive idea has
to have been exploited in its entirety ; ii) the infringing product/method has
to reach the same technical result as the patented invention; iii) the
differences between the infringing product/method and the patented product/method
have to be obvious for the man skilled in the art; and iv) the infringing
solution has to be equivalent to the patented solution.
However, the
court ruled that the doctrine of equivalence will not apply if one of the
following two circumstances are present, in which case infringement by equivalence will not be at all considered, namely i) the invention in question is far removed from the prior art; or ii) where the patent holder has purposely delimited the scope of protection of the
patented invention ( with respect to either novelty or inventive step).
Answering
the question as to whether the Easypark criteria are fulfilled in the instant
case, the court answered in the affirmative.
It then determined that the delimitation made in the context of the specific patent applicant did not
constitute such a restriction that would exclude the application of the
principle of equivalence.
This case
is particularly enlightening in its
discussion about the application of the principle of equivalence. One
further conclusion that can be drawn from the case is that it might be in the
interest of the alleged infringer to consider the entire patent application file in a patent infringement action, because there could be evidence that might
serve to exclude the application of the
principle of equivalence.
The Alfa Laval ./. SWEP case
The Alfa
Laval ./. SWEP case concerned a process patent.
The court elaborated particularly on the issue of burden of proof and
how to allocate it between the patent
holder and the alleged infringer. It is noted that this is the first time the
Swedish Court elaborates on the burden
of proof regarding process patents. Against this backdrop, the court ruled that the patent holder must show that it is probable (“sannolikt”) that
the patented process was used. If he
does, the alleged infringer will then have to show that it is probable that another
method was used instead.
In support of its reasoning, the court (unusually for a
Swedish court) makes direct reference to
Article 34 TRIPS and Article 55 of the
Unitary Patent Court Agreement.
Statistics
This presentation included even some interesting
statistics. During 2018, the Swedish Patent and Market Court received 27 new
lawsuits, while it reached a final
ruling in 24 cases (seven of which concerned a preliminary injunction). At the
same time, the Swedish Patent and Market Court of Appeal received five new
lawsuits and reached a final ruling in seven cases (two of which concerned a preliminary
injunction). Since both courts are still rather new, (having been established only
in 2016), these data about the number of filings and adjudications by these
two specialized courts is noteworthy.
Swedish patent case-law and 2018 patent highlights
Reviewed by Frantzeska Papadopoulou
on
Tuesday, January 22, 2019
Rating:
No comments:
All comments must be moderated by a member of the IPKat team before they appear on the blog. Comments will not be allowed if the contravene the IPKat policy that readers' comments should not be obscene or defamatory; they should not consist of ad hominem attacks on members of the blog team or other comment-posters and they should make a constructive contribution to the discussion of the post on which they purport to comment.
It is also the IPKat policy that comments should not be made completely anonymously, and users should use a consistent name or pseudonym (which should not itself be defamatory or obscene, or that of another real person), either in the "identity" field, or at the beginning of the comment. Current practice is to, however, allow a limited number of comments that contravene this policy, provided that the comment has a high degree of relevance and the comment chain does not become too difficult to follow.
Learn more here: http://ipkitten.blogspot.com/p/want-to-complain.html